Risk stratification model based on estimated dose of radiation to immune cells and radiotherapy-related nadir lymphocyte count for predicting the efficacy of consolidation immunotherapy in stage III non-small cell lung cancer - Top-Institutions - MDSpire

Risk stratification model based on estimated dose of radiation to immune cells and radiotherapy-related nadir lymphocyte count for predicting the efficacy of consolidation immunotherapy in stage III non-small cell lung cancer

  • By

  • Wenlu Chen

  • Yu Liang

  • Qing Hou

  • Xin Cao

  • Anqi Zhao

  • Baixue Wu

  • Yuying Zhou

  • Wenbo Zhang

  • Meng Zhao

  • Ningning Yao

  • Feng Li

  • Jianchun Duan

  • Shuangping Zhang

  • Ning Li

  • Jianzhong Cao

  • July 9, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    GARNET trial
    GARNET trial

    N/A, N/A

    Key Differentiators

    • Oncology

  • #2

    The University of Hong Kong
    The University of Hong Kong

    Hong Kong, N/A

    Key Differentiators

    • Oncology

  • #3

    Washington University School of Medicine
    Washington University School of Medicine

    St. Louis, Missouri

    Key Differentiators

    • Oncology

  • #4

    Sarah Cannon Research Institute
    Sarah Cannon Research Institute

    Nashville, Tennessee

    Key Differentiators

    • Oncology

  • #5

    Levine Cancer Institute, Atrium Health
    Levine Cancer Institute, Atrium Health

    Charlotte, North Carolina

    Key Differentiators

    • Oncology

Original Source(s)

Risk stratification model based on estimated dose of radiation to immune cells and radiotherapy-related nadir lymphocyte count for predicting the efficacy of consolidation immunotherapy in stage III non-small cell lung cancer

  • by Wenlu Chen, Yu Liang, Qing Hou, Xin Cao, Anqi Zhao, Baixue Wu, Yuying Zhou, Wenbo Zhang, Meng Zhao, Ningning Yao, Feng Li, Jianchun Duan, Shuangping Zhang, Ning Li, Jianzhong Cao

  • July 9, 2026

Related Content

Identification and validation of prognostic genes associated with clear cell renal cell carcinoma: based on public whole transcriptome sequencing datasets

Implementing exercise interventions in pediatric oncology: an expert consensus framework from the FORTEe project

Targeted lipid metabolism screening uncovers regulatory effects on the STING immune response in mevalonate, eicosanoid and fatty acid pathways